BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38678337)

  • 1. [Intraductal mixed acinar ductal carcinoma of pancreas: report of a case].
    Yu J; Xiao GX; Liu C; Xie LL; Yang XP; Zheng LD
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):501-503. PubMed ID: 38678337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-Catenin
    Gao C; Chen G; Zhang DH; Zhang J; Kuan SF; Hu W; Esni F; Gao X; Guan JL; Chu E; Hu J
    Cell Mol Gastroenterol Hepatol; 2019; 8(4):561-578. PubMed ID: 31330317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.
    Shi C; Merchant N; Newsome G; Goldenberg DM; Gold DV
    Arch Pathol Lab Med; 2014 Feb; 138(2):220-8. PubMed ID: 24476519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brush cytology of acinar cell carcinoma of the pancreas with intraductal growth: a case report.
    Toyonaga Y; Yamazaki K; Yamada M; Koyasu T; Koyama Y; Ishida Y
    Diagn Cytopathol; 2014 Apr; 42(4):321-4. PubMed ID: 24376257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
    Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
    Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma.
    Grützmann R; Lüttges J; Sipos B; Ammerpohl O; Dobrowolski F; Alldinger I; Kersting S; Ockert D; Koch R; Kalthoff H; Schackert HK; Saeger HD; Klöppel G; Pilarsky C
    Br J Cancer; 2004 Mar; 90(5):1053-8. PubMed ID: 14997207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum metabolomic analysis of pancreatic cancer--response.
    Kobayashi T; Nishiumi S; Yoshida M; Azuma T
    Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1922. PubMed ID: 24097202
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum metabolomic analysis of pancreatic cancer--letter.
    Shakour S; Ruffin MT; Zick SM; Lubman DM; Nie S
    Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1921. PubMed ID: 24097201
    [No Abstract]   [Full Text] [Related]  

  • 9. Acinar cell carcinoma with prominent intraductal growth pattern: case report and review of the literature.
    Toll AD; Mitchell D; Yeo CJ; Hruban RH; Witkiewicz AK
    Int J Surg Pathol; 2011 Dec; 19(6):795-9. PubMed ID: 19584100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
    Grippo PJ; Sandgren EP
    Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acinar cell carcinoma of the pancreas with intraductal growth: report of a case.
    Hashimoto M; Matsuda M; Watanabe G; Mori M; Motoi N; Nagai K; Ishibashi M
    Pancreas; 2003 Apr; 26(3):306-8. PubMed ID: 12657959
    [No Abstract]   [Full Text] [Related]  

  • 12. [Extension of an acinar cell pancreatic carcinoma with cystic changes invading the Wirsung canal].
    Joubert M; Fiche M; Hamy A; Heymann MF; Sagan C; Valette PJ; Le Bodic MF
    Gastroenterol Clin Biol; 1998 Apr; 22(4):465-8. PubMed ID: 9762278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed acinar-neuroendocrine-ductal carcinoma of the pancreas: a tale of three lineages.
    Anderson MJ; Kwong CA; Atieh M; Pappas SG
    BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27257019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohistochemical study of mucins in chronic pancreatitis and ductal adenocarcinoma of the pancreas].
    Paklina OV; Setdikova GR
    Arkh Patol; 2008; 70(4):13-7. PubMed ID: 18807519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis.
    Xiao W; Hong H; Awadallah A; Zhou L; Xin W
    PLoS One; 2014; 9(1):e86853. PubMed ID: 24489794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways.
    Cao D; Maitra A; Saavedra JA; Klimstra DS; Adsay NV; Hruban RH
    Mod Pathol; 2005 Jun; 18(6):752-61. PubMed ID: 15696124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acinar cell carcinoma of the pancreas with intraductal growth: report of a case.
    Imamura M; Kimura Y; Ito H; Nobuoka T; Koito K; Sasaki A; Hirata K
    Surg Today; 2009; 39(11):1006-9. PubMed ID: 19882327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms.
    Basturk O; Zamboni G; Klimstra DS; Capelli P; Andea A; Kamel NS; Adsay NV
    Am J Surg Pathol; 2007 Mar; 31(3):363-70. PubMed ID: 17325477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acinar Cell Carcinoma in the Background of Chronic Calcific Pancreatitis.
    Anand S; Chandrasekar S; Pottakkat B; Rajagopal MD; Badhe B
    J Gastrointest Cancer; 2019 Jun; 50(2):320-323. PubMed ID: 28952013
    [No Abstract]   [Full Text] [Related]  

  • 20. SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms.
    Shroff S; Rashid A; Wang H; Katz MH; Abbruzzese JL; Fleming JB; Wang H
    Hum Pathol; 2014 Mar; 45(3):456-63. PubMed ID: 24418153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.